Several positive and negative regulators (mTOR, SRF, atrogin-1, p62, and myostatin) have been proposed to enhance protein degradation or transcription of muscle-specific genes during both sarcopenia and muscular dystrophy. The gene discussed is FBXO32; the disease is muscular dystrophy.